Biomarker-guided therapy for fungal sepsis produces no better outcomes
The CandiSep trial at Jena University Hospital tested (1,3)-β-D-glucan as biomarker for invasive fungal infection in critically ill patients. The biomarker led to earlier and more frequent antifungal therapy but could not ...
Jul 21, 2022
0
4